ID   HROG38
AC   CVCL_4U50
DR   cancercelllines; CVCL_4U50
DR   CLS; 300879
DR   Wikidata; Q54895327
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 63 hours (CLS=300879).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile224Met (c.672A>G); ClinVar=VCV000189505; Zygosity=Unspecified (CLS=300879).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg234Trp (c.700C>T); ClinVar=VCV000184844; Zygosity=Unspecified (CLS=300879).
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
ST   Source(s): CLS=300879
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 12,13.1
ST   D7S820: 10,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17.1,18.1
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
RX   PubMed=23951083; DOI=10.1371/journal.pone.0071070; PMCID=PMC3737284;
RA   Mullins C.S., Schneider B., Stockhammer F., Krohn M., Classen C.F.,
RA   Linnebacher M.;
RT   "Establishment and characterization of primary glioblastoma cell lines
RT   from fresh and frozen material: a detailed comparison.";
RL   PLoS ONE 8:E71070-E71070(2013).
//